vs
electroCore, Inc.（ECOR）与FONAR CORP（FONR）财务数据对比。点击上方公司名可切换其他公司
FONAR CORP的季度营收约是electroCore, Inc.的2.8倍（$25.5M vs $9.2M）。FONAR CORP净利率更高（8.0% vs -32.8%，领先40.9%）。electroCore, Inc.同比增速更快（31.2% vs 2.4%）。过去两年electroCore, Inc.的营收复合增速更高（30.3% vs -0.3%）
electroCore是一家总部位于美国新泽西州巴斯金里奇的医疗科技公司，于2005年由四位联合创始人创立，现任首席执行官为Daniel S. Goldberger。公司主打产品为gammaCore，是一款已实现商业化的非侵入式设备，通过迷走神经刺激发挥作用。
FONAR是一家专业医疗技术企业，专注于设计、制造及销售包括立式、开放式在内的创新磁共振成像（MRI）设备，主要服务美国的医院、影像诊断中心及医疗机构，为临床诊断提供高精度扫描解决方案。
ECOR vs FONR — 直观对比
营收规模更大
FONR
是对方的2.8倍
$9.2M
营收增速更快
ECOR
高出28.8%
2.4%
净利率更高
FONR
高出40.9%
-32.8%
两年增速更快
ECOR
近两年复合增速
-0.3%
损益表 — Q4 2025 vs Q2 2026
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $25.5M |
| 净利润 | $-3.0M | $2.1M |
| 毛利率 | 88.4% | — |
| 营业利润率 | -31.8% | 13.5% |
| 净利率 | -32.8% | 8.0% |
| 营收同比 | 31.2% | 2.4% |
| 净利润同比 | 6.0% | 4.7% |
| 每股收益（稀释后） | $-0.34 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ECORFONR
| Q4 25 | $9.2M | $25.5M | ||
| Q3 25 | $8.7M | $26.0M | ||
| Q2 25 | $7.4M | $27.3M | ||
| Q1 25 | $6.7M | $27.2M | ||
| Q4 24 | $7.0M | $24.9M | ||
| Q3 24 | $6.6M | $25.0M | ||
| Q2 24 | $6.1M | $25.9M | ||
| Q1 24 | $5.4M | $25.7M |
净利润ECORFONR
| Q4 25 | $-3.0M | $2.1M | ||
| Q3 25 | $-3.4M | $2.3M | ||
| Q2 25 | $-3.7M | $729.3K | ||
| Q1 25 | $-3.9M | $2.5M | ||
| Q4 24 | $-3.2M | $2.0M | ||
| Q3 24 | $-2.5M | $3.1M | ||
| Q2 24 | $-2.7M | $830.4K | ||
| Q1 24 | $-3.5M | $1.9M |
毛利率ECORFONR
| Q4 25 | 88.4% | — | ||
| Q3 25 | 86.0% | — | ||
| Q2 25 | 87.3% | — | ||
| Q1 25 | 84.9% | — | ||
| Q4 24 | 85.9% | — | ||
| Q3 24 | 83.8% | — | ||
| Q2 24 | 86.3% | — | ||
| Q1 24 | 83.7% | — |
营业利润率ECORFONR
| Q4 25 | -31.8% | 13.5% | ||
| Q3 25 | -33.2% | 14.1% | ||
| Q2 25 | -47.5% | 5.3% | ||
| Q1 25 | -56.9% | 15.2% | ||
| Q4 24 | -43.6% | 11.9% | ||
| Q3 24 | -40.4% | 21.0% | ||
| Q2 24 | -42.2% | 7.4% | ||
| Q1 24 | -70.7% | 16.8% |
净利率ECORFONR
| Q4 25 | -32.8% | 8.0% | ||
| Q3 25 | -39.2% | 8.7% | ||
| Q2 25 | -49.7% | 2.7% | ||
| Q1 25 | -57.4% | 9.2% | ||
| Q4 24 | -45.8% | 7.9% | ||
| Q3 24 | -38.1% | 12.6% | ||
| Q2 24 | -43.2% | 3.2% | ||
| Q1 24 | -64.4% | 7.3% |
每股收益（稀释后）ECORFONR
| Q4 25 | $-0.34 | — | ||
| Q3 25 | $-0.40 | — | ||
| Q2 25 | $-0.44 | — | ||
| Q1 25 | $-0.47 | — | ||
| Q4 24 | $-0.37 | — | ||
| Q3 24 | $-0.31 | — | ||
| Q2 24 | $-0.38 | — | ||
| Q1 24 | $-0.53 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.6M | $121.0K |
| 总债务越低越好 | $7.8M | — |
| 股东权益账面价值 | $-1.7M | $176.9M |
| 总资产 | $18.7M | $217.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ECORFONR
| Q4 25 | $11.6M | $121.0K | ||
| Q3 25 | $13.0M | $122.0K | ||
| Q2 25 | $7.1M | $56.5M | ||
| Q1 25 | $7.8M | $123.0K | ||
| Q4 24 | $12.2M | $121.0K | ||
| Q3 24 | $12.9M | $136.0K | ||
| Q2 24 | $14.2M | $56.5M | ||
| Q1 24 | $7.8M | $134.0K |
总债务ECORFONR
| Q4 25 | $7.8M | — | ||
| Q3 25 | $7.8M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $66.9K | ||
| Q1 24 | — | — |
股东权益ECORFONR
| Q4 25 | $-1.7M | $176.9M | ||
| Q3 25 | $-1.1M | $174.9M | ||
| Q2 25 | $1.1M | $172.6M | ||
| Q1 25 | $4.4M | $171.9M | ||
| Q4 24 | $7.5M | $169.8M | ||
| Q3 24 | $9.5M | $168.7M | ||
| Q2 24 | $11.5M | $166.0M | ||
| Q1 24 | $4.5M | $165.8M |
总资产ECORFONR
| Q4 25 | $18.7M | $217.2M | ||
| Q3 25 | $21.4M | $218.4M | ||
| Q2 25 | $14.6M | $216.9M | ||
| Q1 25 | $16.0M | $214.9M | ||
| Q4 24 | $20.5M | $208.0M | ||
| Q3 24 | $21.0M | $212.3M | ||
| Q2 24 | $22.4M | $214.2M | ||
| Q1 24 | $13.9M | $209.6M |
负债/权益比ECORFONR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.5M | $171.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-227.0K |
| 自由现金流率自由现金流/营收 | — | -0.9% |
| 资本支出强度资本支出/营收 | 0.0% | 1.6% |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | $5.7M |
8季度趋势，按日历期对齐
经营现金流ECORFONR
| Q4 25 | $-1.5M | $171.0K | ||
| Q3 25 | $-1.7M | $1.7M | ||
| Q2 25 | $-623.0K | $4.2M | ||
| Q1 25 | $-4.4M | $3.1M | ||
| Q4 24 | $-1.3M | $2.2M | ||
| Q3 24 | $-1.4M | $1.7M | ||
| Q2 24 | $-1.8M | $4.6M | ||
| Q1 24 | $-2.6M | $2.8M |
自由现金流ECORFONR
| Q4 25 | — | $-227.0K | ||
| Q3 25 | $-1.7M | $-177.0K | ||
| Q2 25 | $-648.0K | $3.6M | ||
| Q1 25 | $-4.4M | $2.6M | ||
| Q4 24 | — | $1.5M | ||
| Q3 24 | — | $-148.0K | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | — | $2.6M |
自由现金流率ECORFONR
| Q4 25 | — | -0.9% | ||
| Q3 25 | -19.3% | -0.7% | ||
| Q2 25 | -8.8% | 13.1% | ||
| Q1 25 | -65.4% | 9.4% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | — | -0.6% | ||
| Q2 24 | — | 16.1% | ||
| Q1 24 | — | 10.2% |
资本支出强度ECORFONR
| Q4 25 | 0.0% | 1.6% | ||
| Q3 25 | 0.0% | 7.2% | ||
| Q2 25 | 0.3% | 2.4% | ||
| Q1 25 | 0.6% | 2.2% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 7.2% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 0.7% |
现金转化率ECORFONR
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.75× | ||
| Q2 25 | — | 5.79× | ||
| Q1 25 | — | 1.26× | ||
| Q4 24 | — | 1.14× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 5.54× | ||
| Q1 24 | — | 1.50× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ECOR
暂无分部数据
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
